302 related articles for article (PubMed ID: 6306226)
21. The serotonin/norepinephrine-link in brain. II. Role of serotonin in the regulation of beta adrenoceptors in the low agonist affinity conformation.
Gillespie DD; Manier DH; Sanders-Bush E; Sulser F
J Pharmacol Exp Ther; 1988 Jan; 244(1):154-9. PubMed ID: 2826764
[TBL] [Abstract][Full Text] [Related]
22. Chronic thyroxine treatment of rats down-regulates the noradrenergic cyclic AMP generating system in cerebral cortex.
Schmidt BH; Schultz JE
J Pharmacol Exp Ther; 1985 May; 233(2):466-72. PubMed ID: 2987486
[TBL] [Abstract][Full Text] [Related]
23. Regulation of cyclic AMP content in normal and malignant brain cells.
Perkins JP; Moore MM; Kalisker A; Su YF
Adv Cyclic Nucleotide Res; 1975; 5():641-58. PubMed ID: 165690
[TBL] [Abstract][Full Text] [Related]
24. Electroconvulsive treatment: rapid subsensitivity of the norepinephrine receptor coupled adenylate cyclase system in brain linked to down regulation of beta-adrenergic receptors.
Gillespie DD; Manier DH; Sulser F
Commun Psychopharmacol; 1979; 3(3):191-5. PubMed ID: 227643
[No Abstract] [Full Text] [Related]
25. [Effect of cortisol on adenylate cyclase and 3',5'-AMP phosphodiesterase activity and 3',5'-AMP concentration in tissues and biological fluids in experimental atherosclerosis].
Speranskaia NV; Ozerova IN; Shcherbakova IA; Gerasimova EN
Vopr Med Khim; 1977; (6):777-82. PubMed ID: 202090
[TBL] [Abstract][Full Text] [Related]
26. Altered responsiveness of cerebral beta adrenoceptors assessed by adenosine cyclic 3',5'-monophosphate formation and (3H)propranolol binding.
Nahorski SR
Mol Pharmacol; 1977 Jul; 13(4):679-89. PubMed ID: 196175
[No Abstract] [Full Text] [Related]
27. Alterations in the adenylate cyclase-cAMP-phosphodiesterase system in the locus coeruleus during the development of spontaneous hypertension of the rat.
Bahner U; Schmid G; Palkovits M; Geiger H; Heidland A
J Neurosci Res; 1987; 18(3):473-8. PubMed ID: 2830411
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effect of dietary iodine on the thyroid adenylate cyclase response to thyrotropin in the hypophysectomized rat.
Rapoport B; West MN; Ingbar SH
J Clin Invest; 1975 Aug; 56(2):516-9. PubMed ID: 168233
[TBL] [Abstract][Full Text] [Related]
29. Attenuation of catecholamine-coupled adenylate cyclase following surgical isolation of rat caudate.
Pajer KA; Palmer GC; Chronister RB; Marco LA
J Neurobiol; 1982 May; 13(3):279-88. PubMed ID: 6122717
[TBL] [Abstract][Full Text] [Related]
30. Effect of selected insecticides on rat brain synaptosomal adenylate cyclase and phosphodiesterase.
Kodavanti PR; Mehrotra BD; Chetty SC; Desaiah D
J Toxicol Environ Health; 1988; 25(2):207-15. PubMed ID: 2845111
[TBL] [Abstract][Full Text] [Related]
31. Effect of adrenalectomy and insulin insufficiency upon the adenosine 3', 5' cyclic monophosphate system of the rat mammary glands.
Louis SL; Baldwin RL
J Dairy Sci; 1975 Apr; 58(4):502-6. PubMed ID: 165226
[TBL] [Abstract][Full Text] [Related]
32. Dopamine-beta-hydroxylase: a modulator of beta adrenergic receptor activity.
Thomas JA; Sakai KK; Holck MI; Marks BH
Res Commun Chem Pathol Pharmacol; 1980 Jul; 29(1):3-13. PubMed ID: 6250208
[TBL] [Abstract][Full Text] [Related]
33. Adenylate cyclase and the search for new compounds with the clinical profile of lithium.
Belmaker RH
Pharmacopsychiatry; 1984 Jan; 17(1):9-15. PubMed ID: 6324249
[TBL] [Abstract][Full Text] [Related]
34. Neural control of adenylate cyclase responsiveness in brown adipose tissue.
Granneman JG; MacKenzie RG; Fluharty SJ; Zigmond MJ; Stricker EM
J Pharmacol Exp Ther; 1985 Apr; 233(1):163-7. PubMed ID: 2858577
[TBL] [Abstract][Full Text] [Related]
35. Antidepressant treatments and regulation of norepinephrine-receptor-coupled adenylate cyclase systems in brain.
Sulser F
Adv Biochem Psychopharmacol; 1984; 39():249-61. PubMed ID: 6087628
[No Abstract] [Full Text] [Related]
36. Alpha 1D L-type Ca(2+)-channel currents: inhibition by a beta-adrenergic agonist and pituitary adenylate cyclase-activating polypeptide (PACAP) in rat pinealocytes.
Chik CL; Liu QY; Li B; Klein DC; Zylka M; Kim DS; Chin H; Karpinski E; Ho AK
J Neurochem; 1997 Mar; 68(3):1078-87. PubMed ID: 9048753
[TBL] [Abstract][Full Text] [Related]
37. Putrescine modulation of acute activation of the beta-adrenergic system in the left atrium of rat.
Bordallo C; Cantabrana B; Velasco L; Secades L; Meana C; Méndez M; Bordallo J; Sánchez M
Eur J Pharmacol; 2008 Nov; 598(1-3):68-74. PubMed ID: 18755180
[TBL] [Abstract][Full Text] [Related]
38. Regulation of adenosine 3':5'-monophosphate content of human astrocytoma cells: mechanism of agonist-specific desensitization.
Su YF; Johnson GL; Cubeddu L; Leichtling BH; Ortmann R; Perkins JP
J Cyclic Nucleotide Res; 1976 Jul-AUG; 2(4):271-85. PubMed ID: 184126
[TBL] [Abstract][Full Text] [Related]
39. Receptors, adenylate cyclase, depression, and lithium.
Belmaker RH
Biol Psychiatry; 1981 Apr; 16(4):333-50. PubMed ID: 6261845
[TBL] [Abstract][Full Text] [Related]
40. A low dose of xylamine produces sustained and selective decreases in rat brain norepinephrine without evidence of neuronal degeneration.
Dudley MW; Siegel BW; Ogden AM; McCarty DR
J Pharmacol Exp Ther; 1988 Oct; 247(1):174-9. PubMed ID: 2459367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
